Effects of Stellate Ganglion Block on Early Brain Injury in Patients with Subarachnoid Hemorrhage

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030910

Enrollment

Unknown

Registered

2020-03-17

Start date

2017-12-01

Completion date

Unknown

Last updated

2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aneurysmal subarachnoid hemorrhage

Interventions

Experimental group:Stellate Ganglion Block

Control group:No stellate ganglion block

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Participants who meet the diagnostic criteria for aSAH with aged >=18 years old were recruited for this study.

Exclusion criteria

Exclusion criteria: 1. Participants who meet any of the following criteria are not eligible for this study; 2. Participants have no SAH before surgery; 3. Surgery time exceeds 72 hours of the patients onset; 4. Allergy history of local anesthetics; 5. Participants combined with other severe systemic diseases (Including but not limited to tumor, cardiopulmonary insufficiency and hepatorenal insufficiency); 6. Participants have abnormal in neck structure such as scars and tumors that can not going through the SGB treatment; 7. Participants with coagulation disorders or who is undergoing anticoagulant therapy.

Design outcomes

Primary

Measure	Time frame
IL-1beta, IL-6, TNF-alpha, ET-1, NPY, S100beta, NSE;	—

Contacts

Public ContactZhang Jian

Guangdong 999 Brain Hospital

tzhangjian@126.com+86 13808873093

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 24, 2026